Patents by Inventor Susan S. Wigdal

Susan S. Wigdal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONNEXIN ALLELE DETECTION ASSAYS
    Publication number: 20110111397
    Abstract: The present invention provides compositions and methods for the detection and characterization of mutations associated with non-syndromic hearing impairment. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, for the presence of any one of a collection of mutations in the Connexin 26, or gap junction beta 2, gene associated with non-syndromic hearing loss.
    Type: Application
    Filed: April 20, 2010
    Publication date: May 12, 2011
    Applicant: THIRD WAVE TECHNOLOGIES, INC.
    Inventors: Andrea L. Mast, Erin Dorn, Robert W. Kwiatkowski, JR., Molly Accola, Susan S. Wigdal
  • Connexin allele detection assays
    Patent number: 7700750
    Abstract: The present invention provides compositions and methods for the detection and characterization of mutations associated with non-syndromic hearing impairment. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, for the presence of any one of a collection of mutations in the Connexin 26, or gap junction beta 2, gene associated with non-syndromic hearing loss.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: April 20, 2010
    Assignee: Third Wave Technologies, Inc.
    Inventors: Andrea L. Mast, Erin Dorn, Robert W. Kwiatkowski, Jr., Molly Accola, Susan S. Wigdal
  • CFTR allele detection assays
    Patent number: 7312033
    Abstract: The present invention provides compositions and methods for the detection and characterization of mutations associated with cystic fibrosis. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, for the presence of any one of a collection of mutations in the CFTR gene associated with cystic fibrosis. The present invention also provides compositions, methods and kits for screening sets of CFTR alleles in a single reaction container.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: December 25, 2007
    Assignee: Third Wave Technologies, Inc.
    Inventors: Molly Accola, Susan S. Wigdal, Andrea L. Mast, Christian T. Bartholomay, Robert W. Kwiatkowski, Jr., Vincent Tevere, Hon S. Ip
  • Connexin allele detection assays
    Publication number: 20040203035
    Abstract: The present invention provides compositions and methods for the detection and characterization of mutations associated with non-syndromic hearing impairment. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, for the presence of any one of a collection of mutations in the Connexin 26, or gap junction beta 2, gene associated with non-syndromic hearing loss.
    Type: Application
    Filed: January 9, 2004
    Publication date: October 14, 2004
    Applicant: Third Wave Technologies, Inc.
    Inventors: Andrea L. Mast, Erin Dorn, Robert J. Kwiatkowski, Molly Accola, Susan S. Wigdal
  • CFTR allele detection assays
    Publication number: 20040096844
    Abstract: The present invention provides compositions and methods for the detection and characterization of mutations associated with cystic fibrosis. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, for the presence of any one of a collection of mutations in the CFTR gene associated with cystic fibrosis. The present invention also provides compositions, methods and kits for screening sets of CFTR alleles in a single reaction container.
    Type: Application
    Filed: February 21, 2003
    Publication date: May 20, 2004
    Inventors: Molly Accola, Susan S. Wigdal, Andrea L. Mast, Christian T. Bartholomy, Robert W. Kwiatkowski, Vincent Tevere, Hon S. Ip
  • CFTR allele detection assays
    Publication number: 20040096871
    Abstract: The present invention provides compositions and methods for the detection and characterization of mutations associated with cystic fibrosis. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, for the presence of any one of a collection of mutations in the CFTR gene associated with cystic fibrosis. The present invention also provides compositions, methods and kits for screening sets of CFTR alleles in a single reaction container.
    Type: Application
    Filed: June 26, 2003
    Publication date: May 20, 2004
    Inventors: Molly Accola, Susan S. Wigdal, Andrea L. Mast, Christian T. Bartholomay, Robert W. Kwiatkowski, Vincent Tevere, Hon S. Ip